Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Sequence analysis of the ank gene of granulocytic ehrlichiae.

Massung RF, Owens JH, Ross D, Reed KD, Petrovec M, Bjoersdorff A, Coughlin RT, Beltz GA, Murphy CI.

J Clin Microbiol. 2000 Aug;38(8):2917-22.

2.

Characterization of pneumococcal specific antibodies in healthy unvaccinated adults.

Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J.

Vaccine. 1998 Nov;16(18):1761-7.

PMID:
9778753
3.

Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family.

Murphy CI, Storey JR, Recchia J, Doros-Richert LA, Gingrich-Baker C, Munroe K, Bakken JS, Coughlin RT, Beltz GA.

Infect Immun. 1998 Aug;66(8):3711-8.

4.

Molecular cloning and sequencing of three granulocytic Ehrlichia genes encoding high-molecular-weight immunoreactive proteins.

Storey JR, Doros-Richert LA, Gingrich-Baker C, Munroe K, Mather TN, Coughlin RT, Beltz GA, Murphy CI.

Infect Immun. 1998 Apr;66(4):1356-63.

5.

Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.

Newman MJ, Wu JY, Gardner BH, Anderson CA, Kensil CR, Recchia J, Coughlin RT, Powell MF.

Vaccine. 1997 Jun;15(9):1001-7.

PMID:
9261947
6.

An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis.

Nicholson WL, Comer JA, Sumner JW, Gingrich-Baker C, Coughlin RT, Magnarelli LA, Olson JG, Childs JE.

J Clin Microbiol. 1997 Jun;35(6):1510-6.

7.

Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island.

Yeh MT, Mather TN, Coughlin RT, Gingrich-Baker C, Sumner JW, Massung RF.

J Clin Microbiol. 1997 Apr;35(4):944-7.

8.

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine.

Ma J, Hine PM, Clough ER, Fish D, Coughlin RT, Beltz GA, Shew MG.

Vaccine. 1996 Oct;14(14):1366-74.

PMID:
9004447
9.

Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Ma J, Gingrich-Baker C, Franchi PM, Bulger P, Coughlin RT.

Infect Immun. 1995 Jun;63(6):2221-7.

10.

Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.

Ma J, Bulger PA, Dante S, Davis DR, Perilli-Palmer B, Coughlin RT.

J Infect Dis. 1995 Apr;171(4):909-15.

PMID:
7706819
11.

Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.

Coughlin RT, Fish D, Mather TN, Ma J, Pavia C, Bulger P.

J Infect Dis. 1995 Apr;171(4):1049-52.

PMID:
7706788
12.

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.

Soltysik S, Wu JY, Recchia J, Wheeler DA, Newman MJ, Coughlin RT, Kensil CR.

Vaccine. 1995;13(15):1403-10.

PMID:
8578817
13.

Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines.

Coughlin RT, Fattom A, Chu C, White AC, Winston S.

Vaccine. 1995 Jan;13(1):17-21.

PMID:
7762272
14.

Lyme vaccine enhancement. N-terminal acylation of a protein antigen and inclusion of a saponin adjuvant.

Coughlin RT, Ma J, Cox DE.

Pharm Biotechnol. 1995;6:719-35. Review. No abstract available.

PMID:
7551245
15.

Competence of dogs as reservoirs for Lyme disease spirochetes (Borrelia burgdorferi).

Mather TN, Fish D, Coughlin RT.

J Am Vet Med Assoc. 1994 Jul 15;205(2):186-8.

PMID:
7928571
16.

Characterization of six murine monoclonal antibodies specific for toxin B of Clostridium difficile.

Coughlin RT, Annunziato M, Roberson J, Marciani DJ.

Hybridoma. 1994 Apr;13(2):147-52.

PMID:
8050780
17.

Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes.

Wu JY, Gardner BH, Kushner NN, Pozzi LA, Kensil CR, Cloutier PA, Coughlin RT, Newman MJ.

Cell Immunol. 1994 Apr 1;154(1):393-406.

PMID:
7907530
18.

Detection of HIV-1 IgA by an IgA capture enzyme immunoassay for early diagnosis in infants. NYC Perinatal HIV Transmission Collaborative Study Group.

George JR, Parekh BS, Shaffer N, Coughlin RT, Hung CH, Rogers M, Schochetman G.

Ann N Y Acad Sci. 1993 Oct 29;693:272-4. No abstract available.

PMID:
8267276
19.

HIV-1 specific IgG capture enzyme immunoassay to study the dynamics of HIV-1 antibody and to diagnose HIV-1 infection in infants. NYC Perinatal HIV Transmission Collaborative Study Group.

Parekh B, Shaffer N, Schochetman G, Coughlin RT, Hung CH, George JR.

Ann N Y Acad Sci. 1993 Oct 29;693:268-71. No abstract available.

PMID:
8267275
21.

Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates.

Newman MJ, Wu JY, Coughlin RT, Murphy CI, Seals JR, Wyand MS, Kensil CR.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1413-8.

PMID:
1466970
22.

Potentiation of HIV envelope glycoprotein and other immunogens by endotoxin (ET) and its molecular fragments.

Kovats E, Somlyo B, Csanky E, Shi XM, Zhang YL, Coughlin RT, Nowotny A.

Int J Immunopharmacol. 1992 May;14(4):573-81.

PMID:
1521925
23.

Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.

Newman MJ, Wu JY, Gardner BH, Munroe KJ, Leombruno D, Recchia J, Kensil CR, Coughlin RT.

J Immunol. 1992 Apr 15;148(8):2357-62.

PMID:
1373166
24.

A purified saponin acts as an adjuvant for a T-independent antigen.

White AC, Cloutier P, Coughlin RT.

Adv Exp Med Biol. 1991;303:207-10.

PMID:
1805566
25.

Thin-layer chromatography of endotoxins, their derivatives and contaminants.

Samu J, Kováts E, Nguyen V, Keler T, Nowotny A, Coughlin RT.

J Chromatogr. 1988 Jan 1;435(1):167-83.

PMID:
3280582
26.

Lipopolysaccharide tightly bound to porin monomers and trimers from Escherichia coli K-12.

Rocque WJ, Coughlin RT, McGroarty EJ.

J Bacteriol. 1987 Sep;169(9):4003-10.

29.

A pH titration study on the ionic bridging within lipopolysaccharide aggregates.

Coughlin RT, Peterson AA, Haug A, Pownall HJ, McGroarty EJ.

Biochim Biophys Acta. 1985 Dec 19;821(3):404-12.

PMID:
3000445
30.

Quantitation of metal cations bound to membranes and extracted lipopolysaccharide of Escherichia coli.

Coughlin RT, Tonsager S, McGroarty EJ.

Biochemistry. 1983 Apr 12;22(8):2002-7.

PMID:
6342672
31.

Physical properties of defined lipopolysaccharide salts.

Coughlin RT, Haug A, McGroarty EJ.

Biochemistry. 1983 Apr 12;22(8):2007-13.

PMID:
6303400
32.

A cationic electron spin resonance probe used to analyze cation interactions with lipopolysaccharide.

Coughlin RT, Caldwell CR, Haug A, McGroarty EJ.

Biochem Biophys Res Commun. 1981 Jun 16;100(3):1137-42. No abstract available.

PMID:
6268080
33.

A program for transition point analysis of experimental data.

Brunder DG, Coughlin RT, McGroarty EJ.

Comput Biol Med. 1981;11(1):9-15. No abstract available.

PMID:
7226760
34.

The modification of human erythrocyte membrane structure by membrane stabilizers: an electron spin resonance study.

Janoff AS, Mazorow DL, Coughlin RT, Bowdler AJ, Haug A, McGroarty EJ.

Am J Hematol. 1981;10(2):171-9.

PMID:
6263089
35.

Use of electron spin resonance to study Bacillus megaterium spore membranes.

Janoff AS, Coughlin RT, Racine FM, McGroarty EJ, Vary JC.

Biochem Biophys Res Commun. 1979 Jul 27;89(2):565-70. No abstract available.

PMID:
226087

Supplemental Content

Loading ...
Support Center